These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 96502)
21. Disposition of trilostane in the rat and monkey. Baker JF; Benziger D; Chalecki BW; Clemans S; Fritz A; O'Melia PE; Shargel L; Edelson J Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):4-16. PubMed ID: 6770769 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related]
23. The absorption, distribution, and excretion of 14C-penicillic acid by rats. Park DL; Dailey RE; Friedman L; Heath JL Ann Nutr Aliment; 1977; 31(4-6):919-34. PubMed ID: 613942 [TBL] [Abstract][Full Text] [Related]
24. (14C)Ethylenethiourea: distribution, excretion, and metabolism in pregnant rats. Ruddick JA; Williams DT; Hierlihy WL; Khera KS Teratology; 1976 Feb; 13(1):35-9. PubMed ID: 1257912 [TBL] [Abstract][Full Text] [Related]
25. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys. Emary WB; Toren PC; Mathews B; Huh K Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285 [TBL] [Abstract][Full Text] [Related]
26. The absorption, distribution and metabolic fate of danazol in rats, monkeys and human volunteers. Davison C; Banks W; Fritz A Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):294-310. PubMed ID: 822792 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration. Okuyama Y; Momota K; Morino A Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546 [TBL] [Abstract][Full Text] [Related]
28. Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat. Gerlóczy A; Fónagy A; Keresztes P; Perlaky L; Szejtli J Arzneimittelforschung; 1985; 35(7):1042-7. PubMed ID: 4052138 [TBL] [Abstract][Full Text] [Related]
29. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans. Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731 [TBL] [Abstract][Full Text] [Related]
30. Sucralfate: pharmacokinetics, metabolism and selective binding to experimental gastric and duodenal ulcers in animals. Steiner K; Bühring KU; Faro HP; Garbe A; Nowak H Arzneimittelforschung; 1982; 32(5):512-8. PubMed ID: 6896647 [TBL] [Abstract][Full Text] [Related]
31. Metabolism of p-(cyclopropylcarbonyl)phenylacetic acid (SQ 20,650). Species Differences. Lan SJ; El-Hawey AM; Dean AV; Schreiber EC Drug Metab Dispos; 1975; 3(3):171-9. PubMed ID: 238816 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 1st communication: absorption, distribution and excretion after single administration of 14C-labeled compound to rats and dogs. Nakamura A; Sugihara K; Hirota T; Morino A; Ezumi Y; Takaichi M Arzneimittelforschung; 1997 Feb; 47(2):151-9. PubMed ID: 9079234 [TBL] [Abstract][Full Text] [Related]
33. Species differences in the metabolism of hycanthone. Davison C; Scrime M; Edelson J Arch Int Pharmacodyn Ther; 1977 Nov; 230(1):4-18. PubMed ID: 414666 [TBL] [Abstract][Full Text] [Related]
34. Disposition and metabolism of fenbufen in several laboratory animals. Chiccarelli FS; Eisner HJ; Van Lear GE Arzneimittelforschung; 1980; 30(4A):707-15. PubMed ID: 6776965 [TBL] [Abstract][Full Text] [Related]
35. Biotransformation of diethylstilbestrol in the rhesus monkey and the chimpanzee. Metzler M; Müller W; Hobson WC J Toxicol Environ Health; 1977 Oct; 3(3):439-50. PubMed ID: 411947 [TBL] [Abstract][Full Text] [Related]
36. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of a new positive inotropic agent, 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), in the rat, rabbit, beagle dog and rhesus monkey. Miyamoto G; Sasabe H Arzneimittelforschung; 1984; 34(3A):394-402. PubMed ID: 6540095 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic disposition of guanabenz in the rhesus monkey. Meacham RH; Chiang ST; Kick CJ; Sisenwine SF; Jusko WJ; Ruelius HW Drug Metab Dispos; 1981; 9(6):509-14. PubMed ID: 6120807 [TBL] [Abstract][Full Text] [Related]
39. Disposition of nafarelin acetate, a potent agonist of luteinizing hormone-releasing hormone, in rats and rhesus monkeys. Chu NI; Chan RL; Hama KM; Chaplin MD Drug Metab Dispos; 1985; 13(5):560-5. PubMed ID: 2865103 [TBL] [Abstract][Full Text] [Related]
40. Metabolic disposition of 14C-muroctasin in laboratory animals. Ono K; Masayasu H; Hashimoto F; Yamada M; Takegoshi T Arzneimittelforschung; 1988 Jul; 38(7A):1009-14. PubMed ID: 3190792 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]